文献速递儿科与产科急症呼吸衰竭与机械通气

276,832 例儿科程序性镇静中喉痉挛的预测因素

Predictors of Laryngospasm During 276,832 Episodes of Pediatric Procedural Sedation.
PubMed 文献 · Ann Emerg Med · 2022-06-23
一句话结论多中心前瞻性数据显示,儿科程序性镇静喉痉挛总体发生率为 3.3/1000,上呼吸道感染、气道操作及丙泊酚联合方案与风险升高相关,但绝对风险仍低。

该研究对儿科镇静研究协作组 64 家成员机构连续镇静的 ≤22 岁患者前瞻性数据行二次分析,共纳入 276,832 例次镇静,报告喉痉挛 913 例次,未调整总体发生率为 3.3/1000。多变量模型显示,较低年龄、较高 ASA 分级、合并上呼吸道感染(aOR 3.94,95%CI 2.57–6.03;预测概率 12.2/1000,95%CI 6.3–18.0/1000)及气道操作(aOR 3.73,95%CI 2.33–5.98;预测概率 9.6/1000,95%CI 5.2–13.9/1000)与喉痉挛风险升高相关;与单用丙泊酚相比,丙泊酚+氯胺酮(aOR 2.52,95%CI 1.41–4.50;预测概率 7.6/1000,95%CI 3.1–12/1000)和丙泊酚+右美托咪定(aOR 2.10,95%CI 1.25–3.52;预测概率 6.3/1000,95%CI 3.7–8.9/1000)风险升高。喉痉挛患者中,血氧饱和度低于 70% 持续超过 30 秒占 19.7%,操作未完成占 10.6%,紧急气道干预占 10.0%,气管插管占 5.3%,非计划入院/提高监护级别占 2.3%,误吸占 1.1%,心脏骤停占 0.2%。作者结论认为,尽管多种因素与喉痉挛相关,但预测概率显示喉痉挛发生率仍低,此点应在镇静决策中加以考虑。

要点

  • 儿科程序性镇静喉痉挛总体未调整发生率为 3.3/1000(276,832 例次镇静中 913 例次)。
  • 合并上呼吸道感染与喉痉挛风险升高相关:aOR 3.94(95%CI 2.57–6.03),预测概率 12.2/1000(95%CI 6.3–18.0/1000)。
  • 气道操作与喉痉挛风险升高相关:aOR 3.73(95%CI 2.33–5.98),预测概率 9.6/1000(95%CI 5.2–13.9/1000)。
  • 与单用丙泊酚相比,丙泊酚+氯胺酮(aOR 2.52,95%CI 1.41–4.50)和丙泊酚+右美托咪定(aOR 2.10,95%CI 1.25–3.52)风险升高。
  • 喉痉挛后不良结局:血氧饱和度低于 70% 超过 30 秒 19.7%、紧急气道干预 10.0%、气管插管 5.3%、心脏骤停 0.2%。

适用人群与场景

  • 年龄 ≤22 岁、在儿科镇静研究协作组 64 家成员机构多个地点连续接受程序性镇静的患者。

红旗征与不能漏的情况

  • 合并上呼吸道感染(aOR 3.94,95%CI 2.57–6.03;预测概率 12.2/1000,95%CI 6.3–18.0/1000)。
  • 气道操作(aOR 3.73,95%CI 2.33–5.98;预测概率 9.6/1000,95%CI 5.2–13.9/1000)。
  • 较低年龄和较高 ASA 分级与喉痉挛风险升高相关。

研究设计与关键结果

  • 研究类型:对前瞻性收集数据的二次分析;样本量 276,832 例次镇静,来自 64 家成员机构。
  • 主要结局喉痉挛 913 例次,总体未调整发生率为 3.3/1000。
  • 合并上呼吸道感染:aOR 3.94(95%CI 2.57–6.03),预测概率 12.2/1000(95%CI 6.3–18.0/1000)。
  • 气道操作:aOR 3.73(95%CI 2.33–5.98),预测概率 9.6/1000(95%CI 5.2–13.9/1000)。
  • 与单用丙泊酚相比,丙泊酚+氯胺酮:aOR 2.52(95%CI 1.41–4.50),预测概率 7.6/1000(95%CI 3.1–12/1000)。
  • 与单用丙泊酚相比,丙泊酚+右美托咪定:aOR 2.10(95%CI 1.25–3.52),预测概率 6.3/1000(95%CI 3.7–8.9/1000)。
  • 喉痉挛患者结局:血氧饱和度低于 70% 持续超过 30 秒 19.7%,操作未完成 10.6%,紧急气道干预 10.0%,气管插管 5.3%,非计划入院/提高监护级别 2.3%,误吸 1.1%,心脏骤停 0.2%。

证据类型、等级与局限

  • 证据类型:对前瞻性收集数据的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,喉痉挛的预测概率仍低,此点应在镇静决策中加以考虑。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Laryngospasm is a rare but potentially life-threatening complication of sedation. The objective of this study was to perform a predictor analysis of biologically plausible predictors and the interventions and outcomes associated with laryngospasm.

METHODS: Secondary analysis of prospectively collected data from consecutively sedated patients, less than or equal to 22 years of age, at multiple locations at 64 member institutions of the Pediatric Sedation Research Consortium. The primary outcome was laryngospasm. The independent variables in the multivariable model included American Society of Anesthesiologists category, age, sex, concurrent upper respiratory infection, medication regimen, hospital sedation location, whether the procedure was painful, and whether the procedure involved the airway. The analysis included adjusted odds ratios (aORs) and predicted probabilities.

RESULTS: We analyzed 276,832 sedations with 913 reported events of laryngospasm (overall unadjusted prevalence 3.3:1,000). A younger age, a higher American Society of Anesthesiologists category, a concurrent upper respiratory infection (aOR 3.94, 2.57 to 6.03; predicted probability 12.2/1,000, 6.3/1,000 to 18.0/1,000), and airway procedures (aOR 3.73, 2.33 to 5.98; predicted probability 9.6/1,000, 5.2/1,000 to 13.9/1,000) were associated with increased risk. Compared with propofol alone, propofol combination regimens had increased risk (propofol+ketamine: aOR 2.52, 1.41 to 4.50; predicted probability 7.6/1,000, 3.1/1,000 to 12/1,000; and propofol+dexmedetomidine: aOR 2.10, 1.25 to 3.52; predicted probability 6.3/1,000, 3.7,/1,000 to 8.9/1,000). Among patients with laryngospasm, the resulting outcomes included desaturation less than 70% for more than 30 seconds (19.7%), procedure not completed (10.6%), emergency airway intervention (10.0%), endotracheal intubation (5.3%), unplanned admission/increase in level of care (2.3%), aspiration (1.1%), and cardiac arrest (0.2%).

CONCLUSION: We found increased associations of laryngospasm in pediatric procedural sedation with multiple biologic factors, procedure types, and medication regimens. However, effect estimates showed that the laryngospasm prevalence remained low, and this should be taken into consideration in sedation decisionmaking.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Cosgrove P, Krauss BS, Cravero JP, et al. Predictors of Laryngospasm During 276,832 Episodes of Pediatric Procedural Sedation. Ann Emerg Med. 2022. PMID: 35752522. doi:10.1016/j.annemergmed.2022.05.002

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。